Astec LifeSciences climbs 6% on strong performance despite Covid-19 challenges

Categorised in essential commodities, the company resumed production in its manufacturing plants in a phase-wise manner from April 10, 2020.

from India Infoline News Service https://ift.tt/31dQ3pv